[Long term heparinotherapy and osteoporosis].
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy; D005260:Female; D005598:Fractures, Spontaneous / Q000139:chemically induced; D006493:Heparin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D010024:Osteoporosis / Q000139:chemically induced*; D010146:Pain / Q000139:chemically induced; D010689:Phlebitis / Q000188:drug therapy; D011655:Pulmonary Embolism / Q000188:drug therapy; D012008:Recurrence; D012169:Retinal Vein; D013124:Spinal Injuries / Q000139:chemically induced; D013927:Thrombosis / Q000188:drug therapy
D006493:Heparin
Héparinothérapie au long cours et ostéoporose.